Matteo Materazzi's battle against a rare form of ALS has prompted his wife to launch a fundraiser to fund personalized ...

Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...

Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

A recent study has revealed a critical gap in the use of accessibility features among people living with Amyotrophic Lateral ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death.

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...